trial · primary record
RT-310
BPH (Benign Prostatic Hyperplasia)
| Phase | Phase 1 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 20 |
| Primary completion | 2026-11 |
| Primary endpoint | Absence of unanticipated adverse events (UAEs) not listed in the protocol or Adverse Events (AEs) that meet the protocol definition of Serious Adverse Events (SAEs) |
| Registry ID | NCT06136819 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-02T15:47:02.901Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06136819
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Rt-310 · compound